1. Pink Sheet
  2. >>Geography
  3. >>North America
  4. >>United States

Don't Try This At Home: Zazzle-Created EstroGel Promo Card Fizzles With FDA

 
• By Brenda Sandburg

Low-grade sales piece touting cost savings with Ascend Therapeutics’ product lacks risk information; it is just the seventh Rx citation by FDA this year.

Using an online service to design your own mugs and tee-shirts may seem like a fun idea but applying the program to a drug promotional piece can be risky.

A sales rep for Ascend Therapeutics US LLC appears to have used Zazzle to make a card promoting cost savings with its EstroGel (estradiol gel)

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from United States

More from North America

US FDA Expands Surprise Foreign Inspections But Loses Associate Commissioner Michael Rogers

 
• By Sue Sutter

Commissioner Martin Makary’s repeated characterization of foreign facilities as being subject to lower standards than domestic counterparts may have contributed to Rogers’ decision to retire as head of the recently formed Office of Inspections and Investigations.

Sponsors Like START Rare Disease Pilot, Will Prasad Maintain Its Momentum?

 
• By Kate Rawson

Sponsors reported faster development times for products that joined the pilot program intended to speed rare disease treatments in CBER.

Trump Administration Push For Dismissal, Transfer Of Mifepristone Case Leaves Overhang For Pharma

 
• By Sarah Karlin-Smith

The Trump Administration requested a dismissal or transfer of a lawsuit seeking to tighten the safety requirements for the abortion pill mifepristone on procedural grounds, which still leaves the administration's position on the case's merits unclear.